Risk of QT prolongation through drug interactions between hydroxychloroquine and concomitant drugs prescribed in real world practice

Hydroxychloroquine has recently received attention as a treatment for COVID-19. However, it may prolong the QTc interval. Furthermore, when hydroxychloroquine is administered concomitantly with other drugs, it can exacerbate the risk of QT prolongation. Nevertheless, the risk of QT prolongation due...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Byung Jin, Koo, Yeryung, Kim, Tae Young, Chung, Wou Young, Jung, Yun Jung, Park, Ji Eun, Lim, Hong-Seok, Park, Bumhee, Yoon, Dukyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994840/
https://www.ncbi.nlm.nih.gov/pubmed/33767276
http://dx.doi.org/10.1038/s41598-021-86321-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994840/
https://www.ncbi.nlm.nih.gov/pubmed/33767276
http://dx.doi.org/10.1038/s41598-021-86321-z

Ejemplares similares